COVID-19: FDA Clarifies New Guidance, NCI Role

An official from the US agency focused on new coronavirus diagnostic guidance, testing for asymptomatic individuals, and a National Cancer Institute validation project in a recent teleconference.

FDABldg1ExteriorWithCircle_1200x675

More from Diagnostics

More from Device Area